Compound information
- Natural Products
- ZC1616217
- Molecular Formula
- C26H29N3O8
- Molecular Weight
- 511.195464888 g/mol
- Structure
-
- IUPAC Name
- (2,5-dioxopyrrolidin-1-yl) (2R)-2,6-bis(benzyloxycarbonylamino)hexanoate
- InChI
- InChI=1S/C26H29N3O8/c30-22-14-15-23(31)29(22)37-24(32)21(28-26(34)36-18-20-11-5-2-6-12-20)13-7-8-16-27-25(33)35-17-19-9-3-1-4-10-19/h1-6,9-12,21H,7-8,13-18H2,(H,27,33)(H,28,34)/t21-/m1/s1
- InChI Key
- LHOAUCZIIQFZMI-OAQYLSRUSA-N
- SMILES
- O=C(NCCCC[C@@H](NC(=O)OCc1ccccc1)C(=O)ON1C(=O)CCC1=O)OCc1ccccc1
- Source
- ZINC000103666234
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 37 | Ring Count | 3 |
Heteroatom Count | 11 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 140.34 Å2 | LogP | 2.516 |
LogS | -4.592 | LogD | 2.65 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.045 | Pgp substrate | 0.328 |
HIA | 0.949 | F20 % | 0.974 |
F30 % | 0.0 | Caco-2 | -5.589 |
MDCK | -5.229 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.206 | PPB | 58.521 |
VD | 0.826 | Fu | 0.834 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.05 | CYP1A2 substrate | 0.405 |
CYP2A6 substrate | 0.18 | CYP2B6 substrate | 0.479 |
CYP2C19 inhibitor | 0.859 | CYP2C19 substrate | 0.478 |
CYP2C8 substrate | 0.573 | CYP2C9 inhibitor | 0.787 |
CYP2C9 substrate | 0.67 | CYP2D6 inhibitor | 0.125 |
CYP2D6 substrate | 0.425 | CYP2E1 substrate | 0.342 |
CYP3A4 inhibitor | 0.869 | CYP3A4 substrate | 0.994 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.859 | CL | 4.271 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.169 | Hepatotoxicity | 0.689 |
Mutagenicity | 0.162 | Rat Oral Acute Toxicity | 0.171 |
FDAMDD | 0.298 | Skin Sensitization | 0.323 |
Carcinogenicity | 0.015 | Eye Corrosion | 0.004 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.026 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.284 | IGC50 | 3.565 |
LC50FM | 3.835 | LC50DM | 6.118 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.398 | NR-AR-LBD | 0.237 |
NR-AhR | 0.006 | NR-Aromatase | 0.024 |
NR-ER | 0.356 | NR-ER-LBD | 0.418 |
NR-PPAR-gamma | 0.384 | SR-ARE | 0.649 |
SR-ATAD5 | 0.451 | SR-HSE | 0.484 |
SR-MMP | 0.134 | SR-p53 | 0.533 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.